These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30386245)

  • 1. Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy.
    Saw PE; Zhang A; Nie Y; Zhang L; Xu Y; Xu X
    Front Pharmacol; 2018; 9():1194. PubMed ID: 30386245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy.
    Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC
    Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.
    Xu X; Saw PE; Tao W; Li Y; Ji X; Yu M; Mahmoudi M; Rasmussen J; Ayyash D; Zhou Y; Farokhzad OC; Shi J
    Nano Lett; 2017 Jul; 17(7):4427-4435. PubMed ID: 28636389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.
    Liu Y; Gunda V; Zhu X; Xu X; Wu J; Askhatova D; Farokhzad OC; Parangi S; Shi J
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7750-5. PubMed ID: 27342857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
    Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
    Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
    Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
    Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
    Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
    Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy.
    Xu X; Wu J; Liu S; Saw PE; Tao W; Li Y; Krygsman L; Yegnasubramanian S; De Marzo AM; Shi J; Bieberich CJ; Farokhzad OC
    Small; 2018 Oct; 14(41):e1802565. PubMed ID: 30230235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.
    Xu X; Wu J; Liu Y; Saw PE; Tao W; Yu M; Zope H; Si M; Victorious A; Rasmussen J; Ayyash D; Farokhzad OC; Shi J
    ACS Nano; 2017 Mar; 11(3):2618-2627. PubMed ID: 28240870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.
    Zhu X; Xu Y; Solis LM; Tao W; Wang L; Behrens C; Xu X; Zhao L; Liu D; Wu J; Zhang N; Wistuba II; Farokhzad OC; Zetter BR; Shi J
    Proc Natl Acad Sci U S A; 2015 Jun; 112(25):7779-84. PubMed ID: 26056316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy.
    Li S; Saw PE; Lin C; Nie Y; Tao W; Farokhzad OC; Zhang L; Xu X
    Biomaterials; 2020 Mar; 234():119760. PubMed ID: 31945619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    Fukui N; Yawata T; Nakajo T; Kawanishi Y; Higashi Y; Yamashita T; Aratake T; Honke K; Ueba T
    J Neurosurg; 2021 Jun; 134(6):1772-1782. PubMed ID: 32707539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
    Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
    Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
    Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
    Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
    Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
    Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
    J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.
    Bruun J; Larsen TB; Jølck RI; Eliasen R; Holm R; Gjetting T; Andresen TL
    Int J Nanomedicine; 2015; 10():5995-6008. PubMed ID: 26451106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.